fda warning letters compounded semaglutide september 2025 Warns Novo Nordisk on Unreported Deaths From Crackdown to Collaboration: FDA

The company promises to respond within 5 business days (Lilly Expanded Access)

Fewer side effects: While most weight loss medications come with gastrointestinal side effects like nausea and diarrhea, the dual effect of GLP-1 and GIP means these side effects may be less severe with tirzepatide than alternatives like semaglutide

If you are taking semaglutide (Wegovy) and not losing weight, youre understandably concerned and have questions

None of these mechanisms require diabetes to function

With the increasing popularity of GLP-1 medications for weight loss, many women have questions about interactions between GLP-1 medications and birth control